(Q42919297)

11 November 2017

title

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis (English)

1 reference

11 November 2017

1 reference

1 reference

Michele Pellegrini

6

0 references

Etienne Sokal

object named as

Etienne Sokal

7

0 references

author name string

Steven Black

1

1 reference

11 November 2017

Giovanni Della Cioppa

2

1 reference

11 November 2017

Anne Malfroot

3

1 reference

11 November 2017

Pantaleo Nacci

4

1 reference

11 November 2017

Uwe Nicolay

5

1 reference

11 November 2017

André Vertruyen

8

1 reference

11 November 2017

language of work or name

English

0 references

publication date

15 September 2010

1 reference

11 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

11 November 2017

volume

28

1 reference

11 November 2017

issue

45

1 reference

11 November 2017

page(s)

7331-7336

1 reference

The global state of influenza in children.

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

The rational use of influenza vaccines in healthy children and children with underlying conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Socioeconomic impact of influenza on healthy children and their families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Vaccination and autoimmune disease: what is the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Induction of lupus autoantibodies by adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Safety, immunogenicity and efficacy of influenza vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.075

10.1016/J.VACCINE.2010.08.075

7 January 2021

Identifiers

DOI

1 reference

11 November 2017

1 reference